Active Ingredient(s): Tazemetostat Hydrobromide
FDA Approved: * January 23, 2020
Pharm Company: * EPIZYME INC
Category: Cancer

Tazemetostat, sold under the brand name Tazverik, is a medication used for the treatment of adults and adolescents aged 16 years and older with metastatic (when cancer cells spread to other parts of the body) or locally advanced (when cancer has grown outside the organ it started in, but has not yet spread to distant parts of the body) epithelioid sarcoma not eligible for complete resection (surgically removing all of a tissue, structure, or organ).[1] The most common side eff... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tazverik 200 mg Oral Tablet, Film Coated
NDC: 72607-100
Epizyme, Inc.